28 completed, 11 unknown, 6 recruiting, 4 terminated. 29 Phase 2, 10 Phase 1, 6 Not applicable, 4 Phase 3, 2 Early Phase 1.
Follow Sarcoma, Soft Tissue: new trials by email Literature Review of Sarcoma, Soft Tissue trials Research Report on Sarcoma, Soft Tissue
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients Lab based 3D Gait Assessment, Wearable Inertial Sensors (In Lab and Remote), Functional Testing & Patient Reported Outcomes - Sarcoma, Bone, Sarcoma, Soft Tissue | Recruiting | St. Jude Children's Research Hospital | 300 | 2026-06-16 | 2026-06-18 | |
| Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma Metformin Hydrochloride ER - Sarcoma Metastatic, Sarcoma, Soft Tissue | Phase 2 | Recruiting | Wake Forest University Health Sciences | 50 | 2026-03-04 | 2026-07-23 |
| Short Course of Radiotherapy Prior to Surgery of Soft Tissue Sarcomas Preoperative radiotherapy - Sarcoma of Soft Tissue, Sarcoma | Not applicable | Recruiting | The Netherlands Cancer Institute | 150 | 2025-12-11 | 2026-02-19 |
| Soft Tissue Sarcoma: Motor Performance, Robotic Rehabilitation, Nutrition, and Quality of Life Rehabilitation - Sarcoma, Soft Tissue | Not applicable | Recruiting | Fondazione Policlinico Universitario Campus Bio-Medico | 120 | 2025-03-13 | 2025-03-21 |
| Colorectal Resections in Patients With Retroperitoneal Sarcoma Sarcoma, Soft Tissue, Retroperitoneal Sarcoma | Recruiting | Heidelberg University | 120 | 2025-01-27 | 2026-07-23 | |
| Safety and Efficacy of Degradable Magnesium Metal Clips in Surgical Margins of Radical Surgery for Malignant Bone and Soft Tissue Tumors Biodegradable Magnesium Metal Clips - Sarcoma, Soft Tissue, Sarcoma, Spindle Cell | Not applicable | Not yet recruiting | Guangdong Provincial People's Hospital | 98 | 2024-08-25 | 2024-08-13 |
| Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma DPPG2-TSL-DOX, Dexrazoxane - Sarcoma, Soft Tissue | Phase 1 | Completed | Thermosome GmbH | 8 | 2023-04-19 | 2025-07-28 |
| Efficacy and Safety Study of Cardunilizumab in Soft Tissue Sarcoma Cardunilizumab - Sarcoma, Soft Tissue | Early Phase 1 | Unknown | Xiangya Hospital of Central South University | 15 | 2022-11-01 | 2023-11-02 |
| Immunotherapy Combined With Radiotherapy for Metastatic Sarcoma Pembrolizumab, Radiation therapy - Sarcoma, Soft Tissue | Early Phase 1 | Active not recruiting | University of California, Irvine | 8 | 2022-08-03 | 2026-10-19 |
| A Phase II Study for 609A in the Treatment of Advanced Undifferentiated Pleomorphic Sarcoma Recombinant anti-PD-1 humanized monoclonal antibody injection - Sarcoma, Soft Tissue | Phase 2 | Unknown | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 30 | 2022-01-25 | 2022-01-14 |
| A Phase 2 Clinical Study of Evaluation of Recombinant Anti-PD-1 Humanized Monoclonal Antibody Injection (609A) Combined With Doxorubicin Hydrochloride in the Treatment of Metastatic/Unresectable Non-specific Soft Tissue Sarcoma 609A, doxorubicin hydrochloride - Sarcoma, Soft Tissue | Phase 2 | Unknown | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 70 | 2021-12-30 | 2021-11-30 |
| The Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue Sarcoma Sintilimab, Doxorubicin Hydrochloride, Ifosfamide - Sarcoma, Soft Tissue | Phase 2 | Unknown | Fudan University | 45 | 2020-04-08 | 2020-07-14 |
| Evaluation of Adaptive Radiation Therapy in Pre-operative or Exclusive Radiation Therapy for Limb Soft Tissues Sarcomas Adaptive radiation therapy - Sarcoma, Soft Tissue | Not applicable | Unknown | Institut Paoli-Calmettes | 61 | 2019-06-20 | 2018-09-21 |
| Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients anlotinib - Sarcoma, Soft Tissue | Phase 2 | Unknown | Liaoning Cancer Hospital & Institute | 47 | 2019-05-20 | 2019-07-09 |
| Metabolic Characteristics of Sarcoma In Vivo Using HP 13-C Magnetic Resonance Spectroscopic Imaging (MRSI) Hyperpolarized 13CPyruvate - Sarcoma, Soft Tissue | Withdrawn | University of Texas Southwestern Medical Center | 2019-01-01 | 2022-04-04 | ||
| Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma Patients Soft-tissue Sarcoma Patients Olaratumab and Trabectedin - Sarcoma, Soft Tissue | Phase 1 | Unknown | Grupo Espanol de Investigacion en Sarcomas | 28 | 2018-09-21 | 2023-03-27 |
| Trabectedin Maintenance Post 1st-line in STS Trabectedin - Sarcoma, Soft Tissue | Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 13 | 2017-11-07 | 2020-09-02 |
| Radiomics for Tumor Grading of Soft Tissue Sarcomas. Sarcoma, Soft Tissue | Completed | Technical University of Munich | 285 | 2017-10-01 | 2019-04-10 | |
| Ph II Nintedanib vs. Ifosfamide in Soft Tissue Sarcoma Nintedanib, Ifosfamide - Sarcoma, Soft Tissue | Phase 2 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 80 | 2017-07-07 | 2021-09-20 |
| Transcutaneous Oxygen as a Predictor of Wound Healing Complications in Preoperatively Radiated Soft Tissue Sarcoma Observational Only - Transcutaneous Oxygen Measurement - Sarcoma, Soft Tissue | Completed | The Cleveland Clinic | 39 | 2016-07-01 | 2021-07-20 |
Showing 20 of 55. Sign in to see all of them.
Sarcoma (55) · Osteosarcoma (6) · Leiomyosarcoma (4) · Liposarcoma (3) · Rhabdomyosarcoma (3) · Dermatofibrosarcoma (2) · Fibrosarcoma (2) · Neoplasm Metastasis (2) · Neoplasms (2) · Sarcoma, Ewing (2) · Sarcoma, Synovial (2) · Bone Neoplasms (1) · Brain Neoplasms (1) · Breast Neoplasms (1) · Hemangiosarcoma (1)
Neoplasms by Histologic Type (55) · Neoplasms, Connective and Soft Tissue (54) · Neoplasms (53) · Neoplasms, Connective Tissue (8) · Neoplasms, Muscle Tissue (7) · Neoplasms, Bone Tissue (6) · Neoplasms by Site (5) · Pathological Conditions, Signs and Symptoms (4) · Myosarcoma (3) · Neoplasms, Adipose Tissue (3) · Pathologic Processes (3) · Neoplasms, Fibrous Tissue (2) · Neoplasms, Nerve Tissue (2) · Neoplastic Processes (2) · Nervous System Diseases (2)
Doxorubicin (9) · Ifosfamide (6) · pazopanib (5) · Trabectedin (4) · Gemcitabine (3) · Radiotherapy (3) · olaratumab (3) · Carboplatin (2) · Dexrazoxane (2) · Docetaxel (2) · 130-nm albumin-bound paclitaxel (1) · Albumin-Bound Paclitaxel (1) · Bendamustine Hydrochloride (1) · Drug Therapy (1) · Etoposide (1)
Eli Lilly and Company (3) · GlaxoSmithKline (3) · St. Jude Children's Research Hospital (3) · Columbia University (2) · European Organisation for Research and Treatment of Cancer - EORTC (2) · Grupo Espanol de Investigacion en Sarcomas (2) · Istituto Clinico Humanitas (2) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. (2) · University Hospital Tuebingen (2) · Washington University School of Medicine (2) · AC Camargo Cancer Center (1) · Abbott (1) · Blaze Bioscience Inc. (1) · Celgene (1) · Cooperative Weichteilsarkom Study Group (1)
United States (24) · Germany (9) · France (7) · Italy (7) · Spain (7) · China (6) · Netherlands (6) · United Kingdom (6) · Belgium (4) · Japan (2) · Poland (2) · Switzerland (2) · Argentina (1) · Australia (1) · Brazil (1)
Armando Santoro, MD (2) · Brian A Van Tine, M.D., Ph.D. (2) · Joerg T. Hartmann, MD (2) · Robert N Taub, MD, PhD (2) · Ademar Lopes, Phd (1) · Alexander Zweibach, MD, PhD (1) · Anne Uyttebroeck, MD, PhD (1) · Bruno Vincenzi, MD, PhD (1) · Cary Presant, MD (1) · Charles Forscher, MD (1) · Hans Gelderblom (1) · Ileana Elias, M.D. (1)
PMID 24504442, PMID 11323136, PMID 11858978, PMID 15733628, PMID 16000093, PMID 18268546, PMID 22067397, PMID 22539091, PMID 22905215, PMID 26303366, PMID 26378637, PMID 26864131, PMID 27291997, PMID 27528847, PMID 27544129, PMID 28391775, PMID 28546135, PMID 28988646, PMID 29451543, PMID 31000377, PMID 31081853, PMID 31143880, PMID 31302071, PMID 31365116, PMID 31401903, PMID 31409302, PMID 31522983, PMID 31957034, PMID 32077895, PMID 32554315, PMID 32827353, PMID 33105807, PMID 33175262, PMID 33798613, PMID 33801399, PMID 34023166, PMID 34062484, PMID 35546669, PMID 36436330, PMID 36568164, PMID 36908679, PMID 37133781, PMID 38449377, PMID 41469069, PMID 42778256, PMID 8425352, PMID 8433390, PMID 8826494, PMID 8973131, PMID 9817120
2016 (2), 2004 (1), 2017 (1), 2023 (1), 261201400046C-0-0-1 (1)